Solventum Corporation (SOLV) Stock Price, Quote & News

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature m...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 651 733 1110

Website: www.solventum.com

Address:

3M Center, Building 275-6W-20 2510 Conway Avenue East St. Paul, Maplewood, United States

Rage_Against_The_Machine Jun. 25 at 8:39 PM

Solventum $SOLV renegotiates Thermo Fisher deal - $4B sale now excludes Water Business. EPS accretion rises to 15-20¢, but margin gains take a hit. Faster close could help debt paydown, but that retained H2O biz better not spring a leak. Q2 call will reveal if this is a liquidity lifeline or just treading water. https://www.sec.gov/Archives/edgar/data/1964738/000196473825000056/solv-20250625.htm

0 · Reply

swingingtech Jun. 11 at 8:18 AM

$SOLV https://wallstreetwaves.com/analyst-update-solv-assigned-sector-weight-rating/

0 · Reply

ZacksResearch Jun. 3 at 4:41 PM

$SOLV just flipped the script — is the turnaround real? Q1 beat + raised guidance = bullish momentum, and the transformation is moving fast even with tariff risks in play. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2483554_TEASER

0 · Reply

ZacksResearch Jun. 3 at 2:33 PM

$SOLV beats Q1 expectations — but should investors hold back? 🤔 📈 EPS of $1.34 topped consensus by 12.6%, with a 4.3% organic sales boost. 🚧 Tariff headwinds could hit EPS by 35 to 45 cents in H2, squeezing margins. Hold your position and check out the full analysis here 👉 https://www.zacks.com/commentary/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-body&ADID=SYND_STOCKTWITS_TWEET_2_2483554_BODY

0 · Reply

JarvisFlow May. 19 at 5:51 PM

Piper Sandler has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 87.

0 · Reply

ZacksResearch May. 9 at 1:48 PM

$SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns. Read more: https://www.zacks.com/stock/news/2466173/solventum-stock-gains-on-q1-earnings-revenue-beat-margins-decline?cid=sm-stocktwits-2-2466173-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2466173_TEASER

0 · Reply

michaeljohn1919 May. 8 at 8:41 PM

$SOLV 🔥🔥🔥

1 · Reply

ahab May. 7 at 12:02 PM

$SOLV traded the 5/1-5/2 move, posts ER 5/8, usually beats, It's a medical spin off from 3M. 65.17 MBAC and top of shadow 4/10/25 bottom of shadows 63 ish. hand grenade down the hole= 1/2 position

0 · Reply

ahab May. 1 at 8:21 PM

$SOLV interesting

1 · Reply

michaeljohn1919 Apr. 30 at 11:42 AM

$SOLV… May 8th!!

0 · Reply

Solventum Named a Best Company to Work for by U.S. News & World Report

Jun 3, 2025, 4:05 PM EDT - 22 days ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

May 11, 2025, 5:07 PM EDT - 6 weeks ago

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

May 9, 2025, 11:02 AM EDT - 6 weeks ago

Solventum Corporation: Cheap, With Caveats

May 8, 2025, 6:11 PM EDT - 6 weeks ago

Solventum beats first-quarter profit estimates on strong surgical product sales

May 8, 2025, 4:05 PM EDT - 6 weeks ago

Solventum to Participate in the 2025 BofA Securities Health Care Conference

May 8, 2025, 4:05 PM EDT - 6 weeks ago

Solventum Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 2 months ago

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Mar 25, 2025, 6:00 PM EDT - 3 months ago

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

Mar 21, 2025, 12:44 PM EDT - 3 months ago

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Mar 20, 2025, 9:00 AM EDT - 3 months ago

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Mar 12, 2025, 8:12 AM EDT - 3 months ago

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Feb 28, 2025, 8:36 AM EST - 4 months ago

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 5:09 PM EST - 4 months ago

Solventum forecasts annual profit above estimates on strong surgical product sales

Feb 27, 2025, 4:05 PM EST - 4 months ago

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Feb 26, 2025, 4:15 PM EST - 4 months ago

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Feb 26, 2025, 3:37 PM EST - 4 months ago

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Feb 26, 2025, 2:50 PM EST - 4 months ago

Trian Comments on Solventum's Sale of its Purification & Filtration Business

TMO

Feb 25, 2025, 10:16 AM EST - 4 months ago

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Feb 25, 2025, 8:56 AM EST - 4 months ago

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

TMO

Feb 25, 2025, 8:39 AM EST - 4 months ago

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

TMO

Feb 25, 2025, 8:32 AM EST - 4 months ago

Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business

TMO

Feb 11, 2025, 8:00 AM EST - 4 months ago

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

Feb 5, 2025, 10:00 AM EST - 5 months ago

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging

Jan 30, 2025, 4:05 PM EST - 5 months ago

Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025

Jan 8, 2025, 1:38 PM EST - 6 months ago

Peltz's Trian Fund says 3M's Solventum spin-off not living up to potential

Jan 8, 2025, 1:01 PM EST - 6 months ago

Trian Issues Open Letter to Solventum Shareholders

Jan 8, 2025, 6:30 AM EST - 6 months ago

The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing

Nov 19, 2024, 6:50 AM EST - 7 months ago

Solventum to Participate in the Piper Sandler Healthcare Conference

Nov 14, 2024, 9:00 AM EST - 7 months ago

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

Nov 8, 2024, 5:16 PM EST - 8 months ago

Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:47 PM EST - 8 months ago

Solventum raises annual profit forecast on strong surgical product sales

Nov 7, 2024, 4:05 PM EST - 8 months ago

Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance

Oct 24, 2024, 11:33 AM EDT - 8 months ago

Solventum Taps Bankers to Explore Sale of Filtration Unit

Oct 15, 2024, 6:50 AM EDT - 9 months ago

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Oct 14, 2024, 7:00 AM EDT - 9 months ago

Solventum Announces Commitment to 100% Renewable Electricity by 2030

Oct 10, 2024, 9:00 AM EDT - 9 months ago

Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer

Oct 9, 2024, 12:17 PM EDT - 9 months ago

Buy 4 October Dividend Aristocrats & Watch 10

ADM AMCR BEN CVX ED FAST FRT

Sep 10, 2024, 1:25 PM EDT - 10 months ago

Buy 4 September Dividend Aristocrats And Watch 6

AMCR APD BEN CVX FAST FRT GPC

Sep 10, 2024, 6:45 AM EDT - 10 months ago

Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy

Aug 28, 2024, 6:50 AM EDT - 10 months ago

Solventum to Participate in Upcoming Investor Conferences

Aug 26, 2024, 11:55 AM EDT - 10 months ago

Lanny's Stock Sales Through June 30, 2024

CIM MDU MMM PARA

Aug 23, 2024, 1:16 PM EDT - 10 months ago

Trade Tracker: Jenny Harrington sells Solventum Corp.

Aug 20, 2024, 9:00 AM EDT - 11 months ago

Solventum autonomous coding listed in Epic Toolbox

Aug 10, 2024, 2:39 PM EDT - 11 months ago

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:08 PM EDT - 11 months ago

Solventum's second-quarter profit falls 70% on higher expenses

Aug 8, 2024, 4:05 PM EDT - 11 months ago

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Jul 27, 2024, 10:10 PM EDT - 11 months ago

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

EHAB MMM VFC

Jul 27, 2024, 8:55 AM EDT - 11 months ago

Activist Trian has a few levers to pull to build shareholder value at Solventum

Jul 22, 2024, 5:48 PM EDT - 1 year ago

Solventum Stock Jumps as Activist Trian Discloses Stake

Rage_Against_The_Machine Jun. 25 at 8:39 PM

0 · Reply

swingingtech Jun. 11 at 8:18 AM

$SOLV https://wallstreetwaves.com/analyst-update-solv-assigned-sector-weight-rating/

0 · Reply

ZacksResearch Jun. 3 at 4:41 PM

0 · Reply

ZacksResearch Jun. 3 at 2:33 PM

0 · Reply

JarvisFlow May. 19 at 5:51 PM

Piper Sandler has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 87.

0 · Reply

ZacksResearch May. 9 at 1:48 PM

0 · Reply

michaeljohn1919 May. 8 at 8:41 PM

$SOLV 🔥🔥🔥

1 · Reply

ahab May. 7 at 12:02 PM

$SOLV traded the 5/1-5/2 move, posts ER 5/8, usually beats, It's a medical spin off from 3M. 65.17 MBAC and top of shadow 4/10/25 bottom of shadows 63 ish. hand grenade down the hole= 1/2 position

0 · Reply

ahab May. 1 at 8:21 PM

$SOLV interesting

1 · Reply

michaeljohn1919 Apr. 30 at 11:42 AM

$SOLV… May 8th!!

0 · Reply

TwitsWits Apr. 26 at 4:43 PM

$SOLV it’s good to know people are still buying stock that’s poisoning our people and humanity but keep it going. Keep these companies going so they poison us some more guess what I work for these motherfuckers and they’re trying to kill me every single day and I don’t own a single fucking stock in this shit.

1 · Reply

bigbulldaddy Apr. 7 at 1:40 PM

$SOLV this theory of mimedix getting bought by solventum might have legs. One of their senior marketers and KCI alum John Tatum just came back to Solventum.

1 · Reply

WarrenDouglasTrader Mar. 28 at 8:59 PM

$SOLV Hows that due diligence going with $MDXG ?

0 · Reply

WarrenDouglasTrader Mar. 22 at 2:52 AM

$SOLV Time to buy MDXG

0 · Reply

NVDAMillionaire Mar. 21 at 3:42 PM

$SOLV Digging SOLV's healthcare innovation play. Spin-off from 3M looks interesting. Watching their ERP transition and segment performance closely. MedSurg segment seems strong. Might take a small entry if Q1 looks clean. great article: https://beyondspx.com/article/solventum-corporation-navigating-a-transformative-journey-in-healthcare-innovation

0 · Reply

GCooter Mar. 14 at 12:49 PM

$SOLV flying today

0 · Reply

swingingtech Mar. 13 at 5:57 PM

$SOLV https://wallstreetwaves.com/secure-a-2-9-annualized-return-by-committing-to-purchase-solventum-at-50-with-options/

0 · Reply

WarrenDouglasTrader Mar. 12 at 8:22 PM

$MDXG Only matter of time till we see PR that $SOLV bought $MDXG Writing is on the wall

1 · Reply

WarrenDouglasTrader Mar. 11 at 6:18 PM

$MDXG Just sell this company! $SOLV needs this portfolio in the worst way.

1 · Reply

ssg90 Mar. 11 at 5:15 PM

$SOLV this sell off is wild lol

0 · Reply

WarrenDouglasTrader Mar. 9 at 3:47 AM

$SOLV Will buy out $MDXG

1 · Reply

JarvisFlow Mar. 5 at 2:10 PM

Morgan Stanley has updated their rating for Solventum ( $SOLV ) to Equal-Weight with a price target of 80.

0 · Reply

Market Cap	12.97B
Revenue (ttm)	8.25B
Net Income (ttm)	478.00M
EPS (ttm)	N/A
PE Ratio	13.42
Forward PE	13.13
Profit Margin	5.79%
Debt to Equity Ratio	2.43

Volume	553,900
Avg Vol	1,021,860
Day's Range	N/A - N/A
Shares Out	173.01M
Stochastic %K	95%
Beta	0.54
Analysts	Sell
Price Target	$81.57